Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. Now, people in China will have access to Wegovy, potentially at a much lower price than in the United States.

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its........

© Salon